NeuroSense Therapeutics Ltd. (NRSN) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
NeuroSense Therapeutics Ltd. (NRSN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $22.1M, listed on NASDAQ, employing roughly 17 people, carrying a beta of 1.58 to the broader market. NeuroSense Therapeutics Ltd. Led by Alon Ben-Noon, public since 2021-12-09.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for NRSN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.